Amyotrophic lateral sclerosis: a focus on disease progression

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS), a neurodegenerative motor neuron disease, was first described in 1869.
• ALS shares molecular pathways with other neurodegenerative conditions like Alzheimer's, Huntington's, and Parkinson's diseases.
• Despite extensive research, the specific molecular targets driving ALS's aggressive progression remain elusive.

Purpose of the Study:

• To review potential biomarkers for amyotrophic lateral sclerosis (ALS) identified in human and animal models.
• To investigate the initial molecular events in the neurodegenerative cascade of ALS.
• To discuss current and future therapeutic strategies for ALS.

Main Methods:

• Literature review of studies on amyotrophic lateral sclerosis (ALS).
• Analysis of potential biomarkers in human and animal models.
• Synthesis of information on neurodegenerative pathways and therapeutic interventions.

Main Results:

• Identified various biomarkers associated with ALS progression.
• Highlighted shared molecular pathways between ALS and other neurodegenerative diseases.
• Emphasized the need to identify early molecular targets specific to ALS.

Conclusions:

• Understanding the unique molecular drivers of ALS is crucial for effective treatment.
• Biomarker discovery is key to identifying novel therapeutic targets for ALS.
• Innovative therapeutic strategies are needed to combat the aggressive nature of ALS.